• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (99)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Public Health  • Public Health, Other  • Drug Therapy  • Adverse Effects  • Alert me on articles by topic  Social Bookmarking   What's this?

Thomas J. Moore, AB; Michael R. Cohen, RPh, MS, ScD; Curt D. Furberg, MD, PhD

Arch Intern Med. 2007;167(16):1752-1759.

Background  The US Food and Drug Administration has operated the Adverse Event Reporting System since 1998. It collects all voluntary reports of adverse drug events submitted directly to the agency or through drug manufacturers.

Methods  Using extracts published for research use, we analyzed all serious adverse drug events and medication errors in the United States reported to the Food and Drug Administration from 1998 through 2005.

Results  From 1998 through 2005, reported serious adverse drug events increased 2.6-fold from 34 966 to 89 842, and fatal adverse drug events increased 2.7-fold from 5519 to 15 107. Reported serious events increased 4 times faster than the total number of outpatient prescriptions during the period. In a subset of drugs with 500 or more cases reported in any year, drugs related to safety withdrawals accounted for 26% of reported events in that group in 1999, declining to less than 1% in 2005. For 13 new biotechnology products, reported serious events grew 15.8-fold, from 580 reported in 1998 to 9181 in 2005. The increase was influenced by relatively few drugs: 298 of the 1489 drugs identified (20%) accounted for 407 394 of the 467 809 events (87%).

Conclusions  These data show a marked increase in reported deaths and serious injuries associated with drug therapy over the study period. The results highlight the importance of this public health problem and illustrate the need for improved systems to manage the risks of prescription drugs.

Author Affiliations: Institute for Safe Medication Practices, Huntingdon Valley, Pennsylvania (Mr Moore and Dr Cohen); and Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina (Dr Furberg).

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pharmacoepidemiology in the Postmarketing Assessment of the Safety and Efficacy of Drugs in Older Adults
Hilmer et al.
J Gerontol A Biol Sci Med Sci 2012;67A:181-188.
ABSTRACT | FULL TEXT  

The FDA Drug Safety Surveillance Program: Adverse Event Reporting Trends
Weiss-Smith et al.
Arch Intern Med 2011;171:591-593.
FULL TEXT  

Genetic Polymorphism and Toxicology--With Emphasis on Cytochrome P450
Johansson and Ingelman-Sundberg
Toxicol Sci 2011;120:1-13.
ABSTRACT | FULL TEXT  

Potential for Electronic Health Records and Online Social Networking to Redefine Medical Research
Pearson et al.
Clin. Chem. 2011;57:196-204.
ABSTRACT | FULL TEXT  

Drug-induced liver injury in older adults
Mitchell and Hilmer
Therapeutic Advances in Drug Safety 2010;1:65-77.
ABSTRACT  

Pharmacists' role in ensuring safe and effective hospital use of insulin
Cohen
Am J Health Syst Pharm 2010;67:S17-S21.
ABSTRACT | FULL TEXT  

Adverse Drug Responses: An Increasing Threat to the Well-being of Older Patients: Comment on "Development and Validation of a Score to Assess Risk of Adverse Drug Reactions Among In-Hospital Patients 65 Years or Older"
Schneider and Campese
Arch Intern Med 2010;170:1148-1149.
FULL TEXT  

Eight Tips for Implementing New Technologies in Health Care
Wilson et al.
Ergonomics in Design: The Quarterly of Human Factors Applications 2010;18:20-25.
ABSTRACT  

Balancing Hypoglycemia and Glycemic Control: A Public Health Approach for Insulin Safety
Pogach and Aron
JAMA 2010;303:2076-2077.
FULL TEXT  

Improving Medication Error Reporting in Hospice Care
Boyer et al.
AM J HOSP PALLIAT CARE 2009;26:361-367.
ABSTRACT  

Controlling Off-Label Medication Use
Gillick
ANN INTERN MED 2009;150:344-347.
ABSTRACT | FULL TEXT  

Quality indicators for diabetes mellitus in the ambulatory setting: using the Delphi method to inform performance measurement development
Aron and Pogach
BMJQS 2008;17:315-317.
FULL TEXT  

Antibiotics for Acute Respiratory Infections: Shrinking Benefit, Increasing Risk, and the Irrelevance of Antimicrobial Resistance
Linder
Clinical Infectious Diseases 2008;47:744-746.
FULL TEXT  

Paediatric Bipolar Disorder
Parry and Allison
Australas Psychiatry 2008;16:293-293.
FULL TEXT